C

China Resources Pharmaceutical Group Ltd
HKEX:3320

Watchlist Manager
China Resources Pharmaceutical Group Ltd
HKEX:3320
Watchlist
Price: 4.87 HKD 0.41%
Market Cap: 30.6B HKD

Intrinsic Value

The intrinsic value of one China Resources Pharmaceutical Group Ltd stock under the Base Case scenario is 15.31 HKD. Compared to the current market price of 4.87 HKD, China Resources Pharmaceutical Group Ltd is Undervalued by 68%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
15.31 HKD
Undervaluation 68%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation History
China Resources Pharmaceutical Group Ltd

China Resources Pharmaceutical Group Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for China Resources Pharmaceutical Group Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

China Resources Pharmaceutical Group Ltd
HKEX:3320
HK
Pharmaceuticals
Market Cap
30.6B HKD
IPO
Oct 28, 2016
HK
Pharmaceuticals
Market Cap
30.6B HKD
IPO
Oct 28, 2016
Price
HK$false
EPS
HK$false
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about China Resources Pharmaceutical Group Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about China Resources Pharmaceutical Group Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
China Resources Pharmaceutical Group Ltd

Current Assets 185.8B
Cash & Short-Term Investments 44.6B
Receivables 95.4B
Other Current Assets 45.8B
Non-Current Assets 71.9B
Long-Term Investments 7.8B
PP&E 25.9B
Intangibles 30.9B
Other Non-Current Assets 7.3B
Efficiency

Free Cash Flow Analysis
China Resources Pharmaceutical Group Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
China Resources Pharmaceutical Group Ltd

Revenue
257.7B HKD
Cost of Revenue
-217B HKD
Gross Profit
40.7B HKD
Operating Expenses
-27.7B HKD
Operating Income
13B HKD
Other Expenses
-9.7B HKD
Net Income
3.4B HKD
Fundamental Scores

Profitability Score
Profitability Due Diligence

China Resources Pharmaceutical Group Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
ROIC is Increasing
50/100
Profitability
Score

China Resources Pharmaceutical Group Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

China Resources Pharmaceutical Group Ltd's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Short-Term Solvency
Long-Term Solvency
47/100
Solvency
Score

China Resources Pharmaceutical Group Ltd's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
China Resources Pharmaceutical Group Ltd

Wall Street analysts forecast China Resources Pharmaceutical Group Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for China Resources Pharmaceutical Group Ltd is 7.16 HKD with a low forecast of 5.96 HKD and a high forecast of 9.03 HKD.

Lowest
Price Target
5.96 HKD
22% Upside
Average
Price Target
7.16 HKD
47% Upside
Highest
Price Target
9.03 HKD
85% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for China Resources Pharmaceutical Group Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one China Resources Pharmaceutical Group Ltd stock?

The intrinsic value of one China Resources Pharmaceutical Group Ltd stock under the Base Case scenario is 15.31 HKD.

Is China Resources Pharmaceutical Group Ltd stock undervalued or overvalued?

Compared to the current market price of 4.87 HKD, China Resources Pharmaceutical Group Ltd is Undervalued by 68%.

Back to Top